Daratumumab for refractory immune‐mediated thrombotic thrombocytopenic purpura-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Daratumumab for refractory immune‐mediated thrombotic thrombocytopenic purpura

Published:2023-05-14 Issue:2 Volume:202 Page:429-433
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Aggarwal Asha¹^ORCID,White Danielle²,Pavord Sue¹^ORCID,Thomas Will²^ORCID,Desborough Michael J. R.¹³^ORCID

Affiliation:

1. Department of Clinical Haematology Oxford University Hospitals NHS Foundation Trust Oxford UK

2. Department of Clinical Haematology Cambridge University Hospitals NHS Foundation Trust Cambridge UK

3. Radcliffe Department of Medicine University of Oxford Oxford UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18854

Reference14 articles.

1. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

2. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies

3. Real-world experience with caplacizumab in the management of acute TTP

4. Mycophenolate mofetil in a case of relapsed, refractory thrombotic thrombocytopenic purpura

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of daratumumab in multiresistant immune‐mediated thrombotic thrombocytopenic purpura;British Journal of Haematology;2024-09-04

2. Efficacy of thrombopoietin receptor agonists versus rituximab in non‐responsive immune thrombocytopenia—A single centre retrospective analysis;British Journal of Haematology;2024-07-07

3. Plasma cell‐directed therapy strategies in immune‐mediated thrombotic thrombocytopenic purpura (iTTP);Transfusion;2024-01-18

4. Daratumumab for autoimmune diseases: a systematic review;RMD Open;2023-12

5. Successful Use of Bortezomib in an Adolescent with Refractory TTP;Case Reports in Hematology;2023-11-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3